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Abstract 
One of the major obstacles in developing multifunctional drugs for the metabolic syndrome 
(MS) is lack of in vitro models that capture more complex features of the disease. Here we give 
the first report that establishes an energy metabolic system model using cell-assembly technique 
which can assemble cells into designated places to form complex three-dimensional structures. 
Adipose-derived stromal cells were assembled and induced differentiation into adipocytes and 
endothelial cells; pancreatic islets were then deposited at designated locations and constituted 
adipoinsular axis with adipocytes. Analysis of the factors involved in energy metabolism showed 
our system could capture more physiological and pathophysiological features of the in vivo energy 
metabolism. Drugs known to have effects on MS showed accordant effects in the systems. 
Construction and study of such multicellular systems could help us better understand pathogenesis 
of MS, develop new technologies for drug discovery, and foster applications in tissue engineering 
and metabolomics profiling. 
 
Researchers have recently developed techniques to fabricate tissues and organs in which both 
cells and biomaterials have carefully defined architectures. Three-dimensional (3-D) bioassembly 
tool is capable of extruding cells and biomaterials into spatially organized, 3-D constructs 1. Cell 
printing equipments can print cells as a stream of drops in 3-D positions that mimic their 
respective positions in organs 2,3. We have recently developed a 3-D cell-assembly technique 
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based on Rapid Prototyping (RP) 4,5. This technique can put different cells and materials into 
designated places to form complex 3-D structures. The designed architecture facilitates cell 
growth, organization and differentiation. Hepatocytes have been assembled with gelatin hydrogel 
to build 3-D structures, in which the viabilities and functions of the cells could remain more than 
60 days 6. 
Tissue engineering endeavored to manufacture tissues and organs, but pay little attention to 
establish physiological system models7,8. However, in study of complex physiological processes, 
there is an increasing demand for in vitro 3-D models that can capture more of the relevant 
complexity than what traditional two-dimensional (2-D) cultures achieve 9-11. In the field of drug 
discovery, high-throughput screening is ineffective due to its failure in capturing complex 
pathological features in vivo environment 12,13. More recently, some in vitro 3-D models have been 
applied in research pattern formation14, tumor growth15 and apoptosis16, but limited to study of 
simple physiologic processes by slow spontaneous aggregation of spheroids with poorly 
controlled structure.  
Metabolic syndrome (MS) is a cluster of growing epidemic diseases including obesity, 
diabetes, hypertension, and atherosclerosis17,18. Recently, the pharmaceutical industry has shown 
great interest in developing drugs that can target MS as a whole 19. Researchers including 
ourselves have devoted to find out drug targets and establish models for MS20-23. However, there 
are still no approved drugs that can reliably reduce all of the metabolic risk factors over the long 
term. One of the major obstacles is the lack of in vitro models that can capture more pathological 
features of MS. MS is largely presented as energy metabolic turbulence and cardiovascular disease 
(CVD); adipocytes and β-cells usually constitute adipoinsular axis to regulate energy 
metabolism24; and endothelial cell dysfunction can connect the pathogenesis of energy metabolic 
turbulence with CVD25. With these mechanisms in mind we attempt to organize the related cells 
to establish MS models. 
Here we report the feasibility of constructing an in vitro multicellular 3-D model of energy 
metabolic system for MS, using our cell-assembly technique. Adipose-derived stromal (ADS) 
cells26,27 were assembled in a well designated 3-D structure and were controlled differentiation 
into adipocytes and endothelial cells based on their respective positions within the structure; 
pancreatic islets were then deposited at designated micro-holes. We also tested the factors 
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involved in energy metabolism and endothelial dysfunction of the multicellular model, tested 
whether chronic exposure to high glucose, a major inducement of MS, could lead to similar 
pathological changes of the multicellular model to MS, and tested whether drugs known to have 
effects on MS manifest accordant effects in the multicellular system. 
RESULTS 
Assembling of 3-D multicellular system 
Considering the important roles of adipocytes, β-cells and endothelial cells in energy 
metabolism and MS pathogenesis, we assumed that these types of cell would be required for 
construction of model for MS. We selected ADS cells isolated from rat, which can differentiate 
into adipocytes and endothelial cells. After several comparative experiments about biocompatible 
materials, we mixed ADS cells with gelatin, alginate and fibrinogen solutions sequentially. A 
software package was employed to fabricate the complex structure model with orderly channels 
(Fig. 1 a). Following the designed model, a nozzle controlled by computer was used to deposit the 
mixture on a glass chip at a temperature of 10 ℃ (gelatin at gel state) and generate 3-D structures 
(Fig. 1 b). Then, alginate was crosslinked with CaCL2 and the fibrinogen with thrombin. Once the 
mixture was crosslinked, the whole construct could be handled easily without losing its integrity; 
cells were homogeneous embedded in the matrices (Fig. 1c, d), and the hydrogel state could 
remain at least 8 weeks. The complete process required only ~20 min. Scanning electron 
micrographs showed the development of extensive extracellular matrix (ECM) and cell 
networks in the structure after 6 days of culture (Fig. 1d). The pancreatic islets (contain β-cells) 
from rat were deposited to designated micro holes in the 3-D structure at the 7th d. Anti-insulin 
immunostaining showed that 90% of the pancreatic islets could keep their integrity of globoid 
shape more than three weeks in the structure (Fig. 1e ). Some envelopes of islet were broken, but 
the β-cells still congregated and kept secreting insulin. (Fig. 1f). 
To test whether ADS cells in the 3-D structure can be controlled differentiate into endothelial 
cells and adipocytes, we examined composition and distribution of the cells in the 3-D structure by 
immunostaining and Oil Red O staining. After 3 days of culture with endothelial growth factor 
(EGF), CD34 (ADS cells and endothelial cells indicator) and CD31 (mature endothelial cells 
indicator) staining revealed that over 90% of ADS cells on the walls of the channels were 
differentiated into mature endothelial cells (CD31+/CD34+) and connected with each other 
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forming vessel-like structure. (Fig. 2a, c, e, f). This differentiation of ADS cells was based on 
EGF inducing (Fig2 b, d) and cell position in the 3-D structure (Fig. 2e, f). From the 4th day, the 
structures were treated with insulin, IBMX and dexamethasone for 3 d. At the 12th day, Oil red O 
staining revealed that ADS cells in the structure differentiated into adipocytes with a spherical 
shape (Fig. 2g). The cells under the walls of the channels were more sensitive to differentiation 
into adipocytes than those on the surface of the walls. However, if not induced with EGF, more 
than 90% of cells on the walls of channels would differentiate into adipocytes (Fig. 2h). 
Dynamic insulin secretion 
To determine whether β-cells assembled in the system can mimic in vivo function, we used a 
perfusion system for a time-dependent estimation of insulin response to glucose stimulation. 
Figure 3 shows the dynamic insulin release patterns of free or assembled β-cells stimulated by 
glucose. In response to 15 mM glucose stimulation, assembled β-cells showed a significant 
increase in insulin secretion compared to free β-cells. To determine whether chronic exposure to 
high glucose could cause pathological changes of the β-cells, we culture free or assembled β-cells 
with high-glucose (15 mM). After 5 days of culture, both free β-cells and assembled β-cells 
showed dramatic decreases in glucose-induced insulin release, and the decrease rate of the 
assembled β-cells was higher than that of the free β-cells. Nateglinide could revise the insulin 
secretion decrease of the assembled and free β-cells; whereas rosiglitazone only had the same 
effects on the assembled β-cells.  
Notably, after pre-cultured with high glucose, the glucose-induced insulin secretion peak of 
the assembled β-cells was delayed compared to normal control, this delay could be revised by 
nateglinide, however, this phenomenon was not observed in the free β-cells. Derangements in the 
kinetics of insulin release, including the decrease and delay of the secretion peak value, were one 
of main characteristics of diabetes28,29. These results are consistent with the other in vivo 
experiments30,31, suggesting that the adipocytes in the 3-D structure could help the β-cells to 
capture more pathologic feature of MS. Further investigation of adipocytokine secretion would 
subsequently reveal the mechanism of this phenomenon. 
Glucose consumption, FFA release, and Adipogenesis 
Glucose consumption and free fatty acids (FFA) mobilization of adipocytes are two basic 
metabolic processes in energy metabolism. To determine the glucose consumption of cells in the 
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2-D, 3-D (without β-cells) and multicellular 3-D (with β-cells) culture systems, we culture the 
cells with 25 mM glucose, and thereafter the media were collected for glucose consumption assays 
(Fig. 4a). Cells in the 3-D structure showed higher glucose consumption than in the 2-D structure, 
seeding β-cells in the 3-D structure significantly enhanced the glucose consumption. Similarly, 
after stimulated with isoproterenol, cells in the 3-D structure showed higher FFA release than in 
the 2-D structure, and the β-cells significantly increase the FFA release of the adipocytes (Fig. 
4b).  
To determine whether long-term exposure to high glucose could cause similar pathological 
changes of glucose and lipid metabolism of MS, we cultured cells with high-glucose (15mM) for 7 
d. Pre-culture with high glucose inhibited the glucose consumption of all culture systems, the 
decrease rates of the multicellular 3-D system was the highest. Rosiglitazone revised the glucose 
consumption inhibited by high glucose, the increase rates of the multicellular 3-D system was the 
highest. Contrarily, pre-culture with high glucose increased the isoproterenol-induced FFA release 
of all culture systems. Rosiglitazone just inhibited the FFA release which increase in the 
multicellular 3-D system. These results suggest that β-cells assembled in the structure facilitate the 
system to mimic glucose and FFA metabolism dysfunction of MS and to show more obvious 
effects of rosiglitazone. 
Synthesize and storage fatty acid with overnutrition is the main function of adipocytes and also 
the pathogenesis of obesity. To test whether high glucose promotes adipogenesis of adipocytes in 
different culture systems, we cultured cells with high glucose. After total of 12 days of culture, the 
adipogenesis of the 2-D, 3-D and multicellular 3-D system were increased by 2.1, 5, and 7.3 folds 
compared to normal level, respectively (Fig 4c). Rosiglitazone could increase the adipogenesis of 
all the groups; the increase rate of the multicellular 3-D culture system was the lowest. These 
results suggest that, in the multicellular 3-D system, the assembled β-cells promote adipogenesis 
of adipocytes, but rosiglitazone has only moderate effect on adipogenesis. These results accord 
with the other in vitro researches32,33. 
 
Adipocytokine 
In addition to the storage of lipid, adipocytes perform an endocrine function by secreting 
adipocytokines to regulate energy metabolism34. To study the adipocytokine secreted by 
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adipocytes, we analyzed the secretion of leptin, resistin, and adiponectin of different culture 
systems. Leptin can inhibit both energy intake and insulin secretion, and is antagonistic to insulin 
action. Leptin secretion of adipocytes in the 3-D structure was higher than that in the 2-D structure; 
β-cells inhibit leptin secretion of adipocytes in the 3-D structure (Fig. 5a). Resistin is capable of 
being antagonistic to insulin action and, thus, may serve as a link between obesity and type 2 
diabetes. Adipocytes in the 3-D structure showed higher resistin secretion than in the 2-D structure 
(Fig. 5b). Adiponectin can increase insulin sensitivity and protect endothelial cells. Adipocytes in 
3-D structure showed higher adiponectin secretion than in 2-D culture (Fig. 5c). These data 
suggest that adipocytes in the 3-D culture systems have higher adipocytokine secretion than in the 
2-D culture system. However β-cells have no obvious effect on normal secretion level of 
adiponectin and resistin, except leptin. 
To determine whether chronic exposure to high glucose can induce pathological changes of 
adipocytokine secretion of adipocytes, we cultured the different systems with high glucose. 
Compared with the normal secretion level, pre-culture with high glucose: (i) increased the leptin 
secretion of all groups; (ii) increased the resistin secretion of all groups; (iii) inhibited the 
adiponectin secretion of all groups; (iv) adipocytokine secretion changes in the multicellular 3-D 
group were more moderate than those in the other groups. Rosiglitazone could restore the leptin, 
resistin, and adiponectin secretion derangement; these effects were more obvious in the 
multicellular 3-D group. These results are consistent with the other in vivo experiments35,36.  
 
Endothelial dysfunction 
Nitric oxide (NO) and endothelin-1 secretion derangements have been identified as major 
contributors to endothelial dysfunction associated with MS 25. To study the NO and endothelin-1 
secretion of endothelial, we cultured different systems with high glucose for two days. After 
stimulated with high glucose, endothelial cells in the 3-D structure showed higher endothelin-1 
secretion rate than in the 2-D culture, and the assembled β-cells increased the endothelin-1 
secretion rate of endothelial in the 3-D structure; Rosiglitazone decreased the endothelin-1 
secretion stimulated by high glucose; the decrease rate of the multicellular 3-D system was the 
highest (Fig. 6a). However, we did not find any obvious modification of NO production in the 
2-D and 3-D systems after stimulating with high glucose, except for the increase of the 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
49
6.
1 
: P
os
te
d 
8 
Ja
n 
20
08
multicellular 3-D system. Rosiglitazone could significantly increase the NO production of the 3-D 
and multicellular 3-D systems, but has no effect on the 2-D system (Fig. 6b).  
Our results suggest that the secretion of β-cells could stimulate the secretions of endothelin-1 
and NO. Insulin plays an important role in inducing endothelin-1 and NO release; Anti-insulin 
could decrease the ET-1 and NO secretion of the multicellular system, but has no significant 
effects on other systems without β-cells. These results suggest that β-cells increase ET-1 and NO 
secretion of culture system largely through secretion insulin, comparing with other culture systems, 
endothelial cells in the multicellular 3-D system could capture more pathological features of MS 
and rosiglitazone had more accordant effects on these systems37,38. 
DISCUSSION 
We here give the first description to the establishment of energy metabolic system model 
with cell-assembly technique. This approach integrates recent advances of tissue engineering, 
stem cell and MS into more efficient and wildly useful methodology. Previous researches 
demonstrated that, in comparison with conventional 2-D cultures, cells in 3-D cultures more 
closely resemble to the in vivo situation with regards to cellular environment, cell shape, gene 
expression and biological behavior39,40. Here we used the cell-assembly technique to design and 
assemble a complex architecture with internal channels, which based on the requirements of 
growth, function, differentiation, signaling of different types of cells, as well as different detecting 
technologies. Results showed that cells in the 3-D structure have higher bioactive viabilities than 
in the 2-D culture system, including insulin secretion, glucose and lipid metabolism, 
adipocytokine secretion, NO and endothelin-1 secretion. These results demonstrated that the 
well-designed 3-D architecture could provide the different types of cells with suitable environment 
that facilitates cells keeping their respective bioactivities and functions. For example, adipocytes 
in our 3-D structures could capture distribution, morphology and bio-behavior features which 
ordinarily appear in vivo environment. These results are consistent with the recent researches of 
3-D cultivation of preadipocytes on Fibrous Polymer Scaffolds41. 
ADS cells are multipotent cells found in adipose tissue and have received more attentions 
recently42. This is the first attempt that ADS cells were controlled differentiation into different 
targeted cell types according to their positions within an orderly 3-D structure. Immunostaining 
tests have demonstrated that EGF could easily induce ADS cells on the walls of the channels to 
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differentiate into mature endothelial cells and form tubular structures throughout the engineered 
3-D structures. Contrarily, after pre-culture with EGF, ADS cells under the walls of the channels 
were more sensitive to differentiation into adipocytes than the cells on the walls. The reasons 
could be explained as: (i) the EGF concentration under the walls of the channels was lower than 
that on the surface of the channels due to the diffusion gradient; (ii) the mechanical properties of 
the surface of the channels could induce the ADS cells to differentiate into endothelial cells more 
easily; (iii) once differentiated into mature endothelial cells, the ADS cells will lost other 
differentiation potentials. Further investigations were needed to confirm these hypotheses. At 
present, one of the major obstacles in engineering thick and complex tissues is the need to 
vascularize the tissue in vitro for maintaining cell viability during tissue growth and inducing 
structural organization43. Our technique has therefore provided a new approach to engineer orderly 
endothelial vessel networks in vitro. 
We organized ADS cells, endothelial cells, adipocytes and β-cell in an orderly 3-D structure 
and mimicked their respective in vivo positions. We hypothesized that these cells could mimic 
energy metabolic system through paracrine and intercellular interactions as that in vivo. The 
results demonstrate that adipocytes in the system could influence the glucose-induced insulin 
secretion kinetics of the β-cells. After long-term exposure to high glucose, adipocytes became 
obese and secreted more FFA, leptin and resistin, which were actively involved in crosstalk with 
β-cell, decreased and delayed the insulin secretion peak value of β-cell44. Moreover, secretions of 
β-cells also affect the functions of adipocytes, such as increasing glucose consumption, FFA 
release and adipogenesis, decreasing leptin release, and increasing homeostasis of adipocytokines 
secretion to high glucose stimulation. Endothelial cells formed vessel wall-like structure on the 
walls of channels and then constructed an endothelial barrier between adipocytes and β-cells as 
that in vivo. In summary, adipocytes and β-cell of the multicellular system constituted adipoinsular 
axis to regulate energy metabolism, secretions from adipocytes and β-cells affected the ET-1 and 
NO release of endothelial cells, all these intercellular interactions are coincidence with those of in 
vivo experiments45,46. Notably, the major inducement of MS, chronic exposure to high glucose, 
causes more similar pathological changes of MS in the multicellular system, including obesity, 
insulin and adipocytokines secretion derangement, insulin resistance, and endothelial cells 
dysfunction. Moreover, drugs that have known effects on MS have shown accordant effects in the 
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system47. 
Establishment of such a multicellular 3-D model of energy metabolic system has broadly 
practical and scientific implications. This model provides the essential steps in pathogenesis study 
and drug discovery of MS in vitro. As MS is a cluster of diseases, this model can also be used in 
drug discovery for obesity, diabetes, hypertension, dyslipidemia, atherosclerosis, respectively. We 
organized these different types of cells in a well-defined geometry, which is compatible with in 
situ assays via standard and confocal microscopy (for example, with nondestructive fluorescent 
probes, immunolabels), biosensor array, as well as bulk assays of cell secretion and gene 
expression. Considering the technique is automatic, versatile, rapid, and high-throughput 
productive, it has potential applications in high-content drug screening technology. Moreover, if 
we assemble cells that isolated from human beings, this 3-D model can capture species specific 
facets in drug discovery. Additionally, construction and study of such multicellular 3-D system 
can not only provide research model for studying the cell-cell interaction, stem cell differentiation, 
and cell organization mechanism, but also provide new approaches for tissue engineering 
(especially for vascularization). This new 3-D system closely mimics the in vivo energy metabolic 
features, so it has potential applications in metabolomics profiling. 
 
METHODS 
Cell culture ADS cells were isolated from rat subcutaneous adipose tissues26. The epididymal 
adipose tissues from Sprague-Dawley rats (100~150 g, Beijing university medica Center of 
Laboratory Animals) were excised, washed sequentially in serial dilutions of betadine and finely 
minced in PBS. Tissues were digested with 0.075% Type II collagenase (sigma) at 37℃ for 30 
min. Neutralized cells were centrifuged to separate mature adipocytes and stromal-vascular 
fraction. Floating adipocytes were removed and pelleted stromal cells were filtered through a 100 
µm cell strainer before plating. ADS cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) containing 10% fetal calf serum (FCS) at 37 °C in an atmosphere of 5% CO2. Cells were 
grown to subconfluence and passaged by standard methods of trypsinization. 
Pancreatic Islets were isolated from the rat pancreas48. Pancreas of SD rats was infused with 
0.2% type V collagenase (Sigma), quickly excised, minced, and incubated at 37 °C for 30 min. 
Neutralized cells was washed in Hank’s solution and centrifuged. Islets were separated using 
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Ficoll gradient centrifugation (Ficoll 400 DL, Sigma). Islets were cultured in DMEM containing 
100 mL/L FCS, 200 kU/L penicillin, 100 mg/L streptomycin, and 2 mmol/L L-glutamine (Gibco) 
at 37 °C in an atmosphere of 5% CO2. Medium was changed every second day. 
 
3-D multicellular system construct and operation The ADS Cells were trypsinized off the 
culture dishes upon subconfluence, washed and quantified. Then cells were mixed with gelatin 
(Tianjin green-island Company), alginate (SIGMA) and fibrinogen (SIGMA) gel (gelatin: alginate: 
fibrinogen, 2:1:1) at a density of 3×107 cells/mL. After mixing, 1 mL of the mixture was loaded 
into a sterilized syringe (1mL, 0.45×16 RW LB). We used a software package (Microsoft, AT6400) 
to design the complex 3-D structure, which consisted of square grids and orderly channels about 
400 um in diameter (Fig1 a). Following the designed structure, a refit nozzle controlled by 
computer was used to deposit the mixture on a glass chip at a temperature of 10 ℃ (Gelatin at 
gel state). The program was run 8 times consecutively at the same position to generation of a 
10×10×2 mm3 3-D configuration with the square pattern. When the process was finished, the 3-D 
structure was crosslinked with 10% CaCL2 for 1 min (crosslink the alginate), washed with DMEM 
three times. Then the 3-D structure was further stabilized by 50µU/ml Thrombin (crosslink the 
fibrinogen) in a culture medium containing DMEM, 10% FCS, 1 µmol/L insulin, EGF and 50 
U/mL aprotinin (Sigma), placed in a CO2 incubator at 37 ℃. After 3 days of culture, the medium 
was switched to another containing 10% FCS, 1 µM insulin, 1 µM dexamethasone, 0.5 mmol/L 
isobutyl-methylxanthine (IBMX; Sigma), and 50 u/mL aprotinin for 3 d. At the 6th day, the 
pancreatic islets were aspirated and deposited at designated position of the 3-D structure. The 
medium was changed every other day. For 2-D control experiment, ADS cells were plated at 
5×105 cells/well plates and induced to adipocytes by IBMX or to endothelial cells by EGF. 
 
Structural analyses by Scanning electron microscopy At the 6th day of culture, the 
multicellular 3-D structure were washed in phosphate buffer (pH 7.4) and fixed with 3% 
glutaraldehyde for 2 h. Then the samples were post-fixed with 0.5% OsO4 and rinsed with PB 
again. The samples were dried in vacuum freeze dryer for 12 h. After dehydrated, samples were 
sputter coated with gold–palladium. All micrographs were obtained in a scanning electron 
microscope (Hitachi S450, JAP)  
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 Immunostaining For inmunofluorescence analyses, the assembled multicellular 3-D structure was 
fixed with 4% glutaraldehyde for 20 min at 20°C, and washed 3 times with PBS. The structure 
was incubated with 50 µg/mL propidium iodide (PI, sigma USA) for 20 min (nuclear staining), 
then the structure were incubate with primary antibodies: rabbit anti-rat:CD31 (1:20 in PBS); 
rabbit anti-rat CD34; rabbit anti-rat insulin (1:50) (all from Santa Cruz, USA) for 30 min 
respectively. And then the structure was incubated with a secondary antibody (FITC-conjugated 
anti rabbit IgG, Santa Cruz, 1:20 in PBS) for 30 min. Finally, the samples were washed with PBS 
and observed by fluorescence microscope (OLYMPUS BX51, JAP) or confocal microscopy (Leica 
TCS SP2, Germany). Image acquisition and analysis were performed using the Applied 
DP-Controller system (OLYMPUS, JAP) and Image-pro Plus 5.0 (Media Cybernetics, USA). 
 
Dynamic insulin secretion experiment We measured Insulin secretion kinetics by perfusion 
experiments. After the islets were deposited in the structure, the structures were precultured in 
normal glucose (5 mM) or high glucose (15 mM) medium. After 5 days, islets in or not in the 3-D 
structures (20 islets/per) were introduced to a 1-mL perfusion chamber and exposed to flowing 
perfusate (DMEM, 0.2 mL/min) with a basal glucose concentration (2mM) for 1 h for islet cell 
starvation. Basal insulin secretion was estimated at the same medium and then switched to a high 
glucose content (15 mM) perfusate and collected every 2 min for 20 min. Then the perfusate was 
returned to the basal solution and collected every 5 min for 15 min. The insulin content of 
collected samples was measured by using a rat insulin ELISA kit according to the manufacturers 
instructions (RB, USA) by a microplate reader (Bio-Rad 550). For drug experiment, rosiglitazone 
(3 µg/mL) and nateglinide (5 µg/mL) were added to the culture medium at the 11th day 
respectively.  
 
Measurement of Glucose consumption, FFA release, and Adipogenesis After seeding the 
islets, the multicellular 3-D system was further cultured in normal glucose (5 mM) or high 
glucose (15 mM) medium for more than 7 d. At the 13th day, we replaced the medium with 
DMEM containing 25 mM glucose. After 24 h, we collected the medium for the measurement of 
glucose consumption. Glucose concentration was measured by Glucose assay kit, (Biovision, 
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USA). Glucose consumption rates were calculated subtracting residual glucose in the treated 
medium from glucose in nontreated medium. For determination of FFA release, we replace the 
medium with DMEM containing 2% fatty acid free BSA and 10 µM isoproterenol at the 15th day. 
Aliquots of the medium were collected and the FFA content was measured with FFA assay kits 
(Nanjing Jiancheng, PRC). For drug experiment, rosiglitazone was added to the culture medium at 
the 11th day. 
We use oil red o staining to indicate the high glucose-induced adipogenesis of adipocyte. 
After seeding the islets, the 3-D multicellular system was cultured in normal glucose (5 mM) or 
high glucose (15 mM) medium for more than 8 d. At the 14th d, the 3-D multicellular system was 
fixed with 10% formalin, stained with 0.1 mg/mL oil red O solution for 2 h. Oil red O dye was 
extracted into isopropanol and absorbance was measured at 510 nm. For drug experiment, 
rosiglitazone (3 µg/mL) was added to the culture medium at the 7th day. 
 
Measurement of Adipocytokine by ELISA After seeding the islets, the multicellular 3-D system 
was cultured in normal glucose (5 mM) or high glucose (15 mM) medium, three day-conditioned 
media were harvested at the 21th day. Leptin, resistin and adiponectin were measured in cell 
culture media using rat leptin ELISA kits (RB, USA), rat resistin ELISA kits (TPI, USA) and rat 
adiponectin ELISA kits (USCNLIFE, USA) respectively. The assays were conducted in 96-well 
microplates according to the manufacture’s recommendations, with a microplate reader. Results 
were expressed as a rate of adipocytokine level to DNA content of the cells. Adipocytes in 2-D 
culture and in 3-D culture without islets were deal with the same process. For drug experiment, 
rosiglitazone (3 µg/mL) was added to the culture medium at the 12th day. 
 
DNA assays Following the measurement of adipocytokine, samples and cell-free structure were 
carefully collected and homogenized, and then digested (0.14 mg/mL papainase in 100 mM 
phosphate buffer with 10mM ethylenediaminetetraacetate, EDTA, and 10 mM cysteine) for 20 h 
at 60 °C, using 2 mL of the enzyme solution per sample [42]. DNA content was determined 
fluorimetrically following the binding of Hoechst 33258 dye (Sigma) using calf thymus type I 
DNA as a standard [61]. The fluorescence of negative, cell-free structure was subtracted from the 
fluorescence values of experimental groups to account for fluorescence of the material alone. 
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 Measurement of ET-1 and NO. After seeding the islets, the multicellular 3-D system was culture 
with 5 mM glucose. At the 13th day, the medium were replaced with DMEM containing 25 mM 
glucose. Two day-conditioned media were harvested at the 15th day. ET-l released into the culture 
media was measured by ELISA kit (RB, USA) according to the manufacturer’s instructions. NO 
concentrations in the culture media were detected by using NO Detection kit (JinMei Biotech Co. 
Ltd.) based on nitrate reductase method. Endothelial cells in 2-D culture and in 3-D culture 
without islets were dealt with the same process. For drug experiment, rosiglitazone (3 µg/ml) was 
added to the culture medium at the 10th day. 
 
Statistical analysis. Statistical analysis was performed by Student’s t-test using both confidence 
interval estimate analysis and t score probability hypothesis testing method for two independent 
sample groups. However, there is a considerable probability of statistical error due to the limited 
numbers of subjects in this study. 
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Figure 1 | Construct and analyses of the multicellular 3-D system. (a) ADS cells in 
prepolymer solution were loaded into a sterilized syringe (1) Computer controlled a refit 
nozzle to deposit the mixture on a glass chip at a temperature of 10 ℃ and generated a 3-D 
structure, which consisted of square grids and orderly channels. (2) The 3-D structure was 
crosslinked by CaCL2 and thrombin respectively, cells embedded in the matrices had a relatively 
stable micro environment. The structure was removed and cultured. (3) At the 7th days, the 
pancreatic islets were deposited into designated micro holes in the structure. (b) The 3-D structure 
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cultured in a plate. (c) Immunostaining of the 3-D structure using mAbs for CD34+ cells in green. 
(d) Scanning electron micrographs showed the development of extensive ECM and cell networks 
in the structure after 6 days of culture. (e) Immunostaining of the pancreatic islets in the 3-D 
structure using anti-insulin in green. 90% of the pancreatic islets can keep integrity globoid shapes 
for more than three weeks in the structure, (f) some envelopes of islets were broken, but the 
β-cells still congregated and kept secreting insulin. 
 
Figure 2 | ADS cells in the 3-D structure could be controlled differentiation into endothelial cells 
and adipocytes. (a, b) Immunostaining of the 3-D structure using mAbs for CD34+ cells (ADS 
cells and endothelial cells) in green and PI for nuclear in red. (c-f) Immunostaining of the 3-D 
structure using mAbs for CD31+cells (mature endothelial cells) in green and PI for nuclear in red. 
ADS cells in the 3-D structure were cultured with EGF (a, c, e, f) or without EGF (b, d). Image of 
(e, f) was observed by confocal microscopy. (g, h) Immunostaining of the 3-D structure using 
mAbs for CD31+ cells in green and Oil red O staining of the 3-D structure for adipocytes in red. 
ADS cells in 3-D structure were culture with EGF (g) or without EGF (h) for three days, and then 
treated with insulin, IBMX and dexamethasone. 
 
Figure 3 | Insulin secretion kinetics of (a) the free islet, (b) the islet assembled in the 3-D structure 
were measured by perfusion experiments. Cells were incubated in normal glucose (NG, 5 mM) or 
high glucose (HG, 15 mM) for 5 d. For drug experiment, rosiglitazone (ROS, 3 µg/ml) or 
nateglinide (NATE, 5 µg/ml) were added to the HG culture medium at the 4th day. Next the cells 
were introduced to a perfusion chamber and exposed to flowing perfusate with a basal glucose 
concentration (2mM) for 1h and then switched to a high glucose content (15 mM) perfusate for 20 
min. Then the perfusate was returned to basal glucose concentration. The insulin content in the 
extracts was determined by ELISA insulin kit. Data are mean±s.d., n=3. 
 
Figure 4 | Measurement of Glucose metabolism and lipid metabolism. Long-term exposure to 
high glucose (HG 15 mM) was used to induce the pathological changes of the cells in different 
culture system. For drug experiment, rosiglitazone (ROS, 3 µg/ml) was added to the HG culture 
medium. (a) Glucose consumption of cells was stimulated with 25 mM glucose and the glucose 
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concentration of the medium was measured with Glucose assay kit. (b) FFA release of cells was 
stimulated with isoproterenol (10 µM) and the FFA content was measured with FFA assay kits. 
Results were expressed as the ratios of the stimulate level to base level. (c) Adipogenesis.was 
stimulated by long exposure to HG and the lipid accumulation was measured with oil red o assay. 
Absorbance is designated as 1.0 for cell cultured in normal glucose. Data are mean±s.d., n=6. 
 
Figure 5 | Adipocytokine secretion of adipocytes in different culture systems. Long-term exposure 
to high glucose (HG 15 mM) was used to induce the pathological changes of the cells in different 
culture system. For drug experiment, rosiglitazone (ROS, 3 µg/ml) was added to the HG culture 
medium. Adipocytokine secretion of adipocytes in different culture system: (a) leptin secretion (b) 
resistin secretion (c) adiponectin secretion. Adipocytokine content in the medium was determined 
by ELISA kit. Results were expressed as the ratios of the adipocytokine secretion level to the 
DNA content of the cells. Data are mean±s.d., n=6. 
 
 
Figure 6 | Endothelin-1 and NO secretion of endothelial in different culture systems. Cells were 
cultured with high glucose (HG 25 mM) for two days. (a) Endothelin-1 concentrations in the 
culture medium were measured by ELISA kit. (b) NO concentrations in the culture medium were 
detected by NO Detection kit. For drug experiment, rosiglitazone (3 µg/ml) was added to the HG 
culture medium. Results were expressed as fold increase to base level. Data are mean±s.d., n=6. 
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Figure 3 | Insulin secretion kinetics of (a) the free islet, (b) the islet assembled in the 3-D structure 
were measured by perfusion experiments. Cells were incubated in normal glucose (NG, 5 mM) or 
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high glucose (HG, 15 mM) for 5 d. For drug experiment, rosiglitazone (ROS, 3 µg/ml) or 
nateglinide (NATE, 5 µg/ml) were added to the HG culture medium at the 4th day. Next the cells 
were introduced to a perfusion chamber and exposed to flowing perfusate with a basal glucose 
concentration (2mM) for 1h and then switched to a high glucose content (15 mM) perfusate for 20 
min. Then the perfusate was returned to basal glucose concentration. The insulin content in the 
extracts was determined by ELISA insulin kit. Data are mean±s.d., n=3. 
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Figure 4 | Measurement of Glucose metabolism and lipid metabolism. Long-term exposure to 
high glucose (HG 15 mM) was used to induce the pathological changes of the cells in different 
culture system. For drug experiment, rosiglitazone (ROS, 3 μg/ml) was added to the HG culture 
medium. (a) Glucose consumption of cells was stimulated with 25 mM glucose and the glucose 
concentration of the medium was measured with Glucose assay kit. (b) FFA release of cells was 
stimulated with isoproterenol (10 μM) and the FFA content was measured with FFA assay kits. 
Results were expressed as the ratios of the stimulate level to base level. (c) Adipogenesis.was 
stimulated by long exposure to HG and the lipid accumulation was measured with oil red o assay. 
Absorbance is designated as 1.0 for cell cultured in normal glucose. Data are mean±s.d., n=6. 
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Figure 5 | Adipocytokine secretion of adipocytes in different culture systems. Long-term exposure 
to high glucose (HG 15 mM) was used to induce the pathological changes of the cells in different 
culture system. For drug experiment, rosiglitazone (ROS, 3 μg/ml) was added to the HG culture 
medium. Adipocytokine secretion of adipocytes in different culture system: (a) leptin secretion (b)
resistin secretion (c) adiponectin secretion. Adipocytokine content in the medium was determined 
by ELISA kit. Results were expressed as the ratios of the adipocytokine secretion level to the 
DNA content of the cells. Data are mean±s.d., n=6. Na
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Figure 6 | Endothelin-1 and NO secretion of endothelial in different culture systems. Cells were 
cultured with high glucose (HG 25 mM) for two days. (a) Endothelin-1 concentrations in the 
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culture medium were measured by ELISA kit. (b) NO concentrations in the culture medium were 
detected by NO Detection kit. For drug experiment, rosiglitazone (3 μg/ml) was added to the HG 
culture medium. Results were expressed as fold increase to base level. Data are mean±s.d., n=6. 
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